
Journal of Diagnostics Concepts & Practice››2022,Vol. 21››Issue (04): 527-529.doi:10.16150/j.1671-2870.2022.04.019
• Case reports •Previous ArticlesNext Articles
Received:2021-05-11Online:2022-08-25Published:2022-11-07Contact:WANG Weiming E-mail:wweiming01@126.comCLC Number:
HAO Xu, WANG Weiming. Fabry disease presenting with renal disease as the main manifestation diagnosed by renal biopsy: a case report[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 527-529.
| [1] | Rombach SM, Hollak CE, Linthorst GE, et al. Cost-effectiveness of enzyme replacement therapy for Fabry disease[J]. Orphanet J Rare Dis, 2013, 8:29. doi:10.1186/1750-1172-8-29pmid:23421808 |
| [2] | 中国法布里病专家协作组. 中国法布里病(Fabry病)诊治专家共识[J]. 中华医学杂志, 2013, 93(4):243-247. |
| Chinese expert collaboration group on Fabry disease. Expert consensus on diagnosis and treatment of Fabry disease in China[J]. Natl Med J China, 2013, 93(4):243-247. | |
| [3] | 潘晓霞, 欧阳彦, 王朝晖, 等. 法布里病83例临床病理特点分析[J]. 中国实用内科杂志, 2014, 34(3):262-266. |
| Pan XX, Ouyang Y, Wang CH, et al. Clinical and pathological characteristics of 83 cases of Fabry disease[J]. Chin J Pract Int Med, 2014, 34(3):262-266. | |
| [4] | MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males[J]. J Med Genet, 2001, 38(11):750-760. pmid:11694547 |
| [5] | Tanaka M, Ohashi T, Kobayashi M, et al. Identification of Fabry′s disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients[J]. Clin Nephrol, 2005, 64(4):281-287. pmid:16240899 |
| [6] | Bekri S, Enica A, Ghafari T, et al. Fabry disease in patients with end-stage renal failure: the potential benefits of screening[J]. Nephron Clin Pract, 2005, 101(1):c33-c38. doi:10.1159/000085709pmid:15886492 |
| [7] | Gal A, Hughes DA, Winchester B. Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group[J]. J Inherit Metab Dis, 2011, 34(2):509-514. doi:10.1007/s10545-010-9261-9pmid:21229318 |
| [8] | Patel V, O'Mahony C, Hughes D, et al. Clinical and genetic predictors of major mardiac events in patients with Anderson-Fabry disease[J]. Heart, 2015, 101(12):961-966. doi:10.1136/heartjnl-2014-306782URL |
| [9] | Hagège A, Réant P, Habib G, et al. Fabry disease in cardiology practice: Literature review and expert point of view[J]. Arch Cardiovasc Dis, 2019, 112(4):278-287. doi:S1875-2136(19)30039-7pmid:30826269 |
| [10] | Yogasundaram H, Kim D, Oudit O, et al. Clinical features, diagnosis, and management of patients with anderson-Fabry cardiomyopathy[J]. Can J Cardiol, 2017, 33(7):883-897. doi:S0828-282X(17)30207-6pmid:28668140 |
| [11] | Schiffmann R, Swift C, McNeill N, et al. Low frequency of Fabry disease in patients with common heart disease[J]. Genet Med, 2018 Jul, 20(7):754-759. doi:10.1038/gim.2017.175pmid:29227985 |
| [12] | Capelli I, Aiello V, Gasperoni L, et al. Kidney transplant in Fabry disease: a revision of the literature[J]. Medicina (Kaunas), 2020, 56(6):284. |
| [1] | LEI Hang, FAN Liangfeng, CAI Xiaohong, WANG Yuqing, LIU Xi, JIN Sha, SHEN Wei, LU Qiong, XIANG Dong, WANG Xuefeng, ZOU Wei.The study on molecular basis of ABO blood subgroups in the Chinese population[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 364-369. |
| [2] | PENG Zhenping, XIANG Xixi, ZHANG Sujiang, LI Jiaming.Chronic neutrophilic leukemia with leukemia-like reaction as the first-onset manifestation: a report of 2 cases and literature review[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 122-128. |
| [3] | CAI Rong, MIN Xuewen, CHEN Meirong, SHEN Yating, SHI Qunli, ZHOU Xiaodie.Expression of BRAF V600E (VE1) in thyroid papillary carcinoma and its clinical significance[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(05): 552-556. |
| [4] | WANG Dengfeng, CUI Wenyan, ZOU Wei, LI Fang, WANG Xuefeng, CAI Xiaohong.Molecular mechanism of Axsubtype caused by p.M142I mutation in alpha 1-3-N-acetylgalactosaminyltransferase[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 260-265. |
| [5] | LU Jing, XU Yufei, QING Yanrong, HAN Cong, LI Niu, YU Tingting, YAO Ruen, WANG Jian.Concurrent gene mutation analysis of a developmental delayed child with Rett syndrome and Noonan syndrome[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(02): 147-150. |
| [6] | JIN Peipei, LIANG Qian, DAI Jing, DING Qiulan, SUN Shunchang, WANG Xuefeng.Phenotype and genotype analysis of a Chinese pedigree with 2N type von Willebrand disease[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(02): 151-154. |
| [7] | WANG Shu, ZHANG Yunxiang, SUI Jingni, LU Jing, FAN Huiyong, WANG Chao, CHEN Bing..Analysis of additional mutation pattern accompanied withCEBPAmutations in patients with the cytogenetically normal acute myeloid leukemia[J]. Journal of Diagnostics Concepts & Practice, 2017, 16(05): 498-503. |
| [8] | .[J]. Journal of Diagnostics Concepts & Practice, 2015, 14(03): 235-238. |
| [9] | .[J]. Journal of Diagnostics Concepts & Practice, 2015, 14(01): 51-57. |
| [10] | .[J]. Journal of Diagnostics Concepts & Practice, 2014, 13(01): 44-48. |
| [11] | .[J]. Journal of Diagnostics Concepts & Practice, 2012, 11(03): 252-257. |
| [12] | .[J]. Journal of Diagnostics Concepts & Practice, 2009, 8(06): 631-634. |
| [13] | .[J]. Journal of Diagnostics Concepts & Practice, 2009, 8(03): 296-301. |
| [14] | .[J]. Journal of Diagnostics Concepts & Practice, 2007, 6(05): 417-420. |
| [15] | .[J]. Journal of Diagnostics Concepts & Practice, 2006, 5(06): 507-510. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
